TLRs are able to induce KC activation towards the M1 phenotype; TLR-4 ablation determines the reduction of liver damage and the depletion of KCs in mice with NASH [115]. This evidence concerns the gene TBCE and metabolic dysfunction-associated steatohepatitis.